Six-month clinical results positive for dual-optic IOL

San Diego-First trial results with the Synchrony dual-optic accommodative IOL (Visiogen Inc.) indicate that this first-generation lens is safe and performs well. However, lens power calculations should improve via more IOL implantation and calculation adjustment, according to Gerd Auffarth, MD.